Intest Res Search

CLOSE


Previous issues

  • HOME
  • BROWSE ARTICLES
  • Previous issue
Volume 20(1); Jan 2022
Editorial
Close layer
prev next
Reviews
Management of inflammatory bowel disease in the COVID-19 era
Kyeong Ok Kim, Byung Ik Jang
Intest Res. 2022;20(1):3-10.   Published online February 3, 2021
Full text    PubReader    ePub    PDF    
Close layer
prev next
Use of thiopurines in inflammatory bowel disease: an update
Arshdeep Singh, Ramit Mahajan, Saurabh Kedia, Amit Kumar Dutta, Abhinav Anand, Charles N. Bernstein, Devendra Desai, C. Ganesh Pai, Govind Makharia, Harsh Vardhan Tevethia, Joyce WY Mak, Kirandeep Kaur, Kiran Peddi, Mukesh Kumar Ranjan, Perttu Arkkila, Rakesh Kochhar, Rupa Banerjee, Saroj Kant Sinha, Siew Chien Ng, Stephen Hanauer, Suhang Verma, Usha Dutta, Vandana Midha, Varun Mehta, Vineet Ahuja, Ajit Sood
Intest Res. 2022;20(1):11-30.   Published online April 15, 2021
Full text    PubReader    ePub    PDF    
Close layer
prev next
Microbiota
The role of microbiome in colorectal carcinogenesis and its clinical potential as a target for cancer treatment
Sang Hoon Kim, Yun Jeong Lim
Intest Res. 2022;20(1):31-42.   Published online May 21, 2021
Full text    PubReader    ePub    PDF    
Close layer
prev next
IBD
An integrative review of physical activity in adults with inflammatory bowel disease
Suja P Davis, Patricia B. Crane, Linda P. Bolin, Lee Ann Johnson
Intest Res. 2022;20(1):43-52.   Published online January 22, 2021
Full text    PubReader    ePub    PDF    Supplementary Material
Close layer
prev next
Original Articles
The dietary practices and beliefs of British South Asian people living with inflammatory bowel disease: a multicenter study from the United Kingdom
Benjamin Crooks, Ravi Misra, Naila Arebi, Klaartje Kok, Matthew J. Brookes, John McLaughlin, Jimmy K. Limdi
Intest Res. 2022;20(1):53-63.   Published online January 6, 2021
Full text    PubReader    ePub    PDF    Supplementary Material
Close layer
prev next
Maintaining infliximab induced clinical remission with azathioprine and 5-aminosalicylates in acute severe steroid-refractory ulcerative colitis has lower cost and high efficacy (MIRACLE): a multicenter study
Ramit Mahajan, Arshdeep Singh, Saurabh Kedia, Kirandeep Kaur, Vandana Midha, Pabitra Sahu, Varun Mehta, Dharmatma Singh, Namita Bansal, Khushdeep Dharni, Sandeep Kaushal, Vineet Ahuja, Ajit Sood
Intest Res. 2022;20(1):64-71.   Published online February 3, 2021
Full text    PubReader    ePub    PDF    
Close layer
prev next
Vedolizumab does not increase perioperative surgical complications in patients with inflammatory bowel disease, cohort study
Vitaliy Y. Poylin, Jose Cataneo Serrato, Jonathan Pastrana Del Valle, Joseph D. Feuerstein
Intest Res. 2022;20(1):72-77.   Published online February 3, 2021
Full text    PubReader    ePub    PDF    
Close layer
prev next
Effectiveness of administering zinc acetate hydrate to patients with inflammatory bowel disease and zinc deficiency: a retrospective observational two-center study
Kensuke Sakurai, Shigeru Furukawa, Takehiko Katsurada, Shinsuke Otagiri, Kana Yamanashi, Kazunori Nagashima, Reizo Onishi, Keiji Yagisawa, Haruto Nishimura, Takahiro Ito, Atsuo Maemoto, Naoya Sakamoto
Intest Res. 2022;20(1):78-89.   Published online January 22, 2021
Full text    PubReader    ePub    PDF    Supplementary Material
Close layer
prev next
Long-term efficacy and tolerability of dose-adjusted thiopurine treatment in maintaining remission in inflammatory bowel disease patients with NUDT15 heterozygosity
Takato Maeda, Hirotake Sakuraba, Hiroto Hiraga, Shukuko Yoshida, Yoichi Kakuta, Hidezumi Kikuchi, Shogo Kawaguchi, Keisuke Hasui, Tetsuya Tatsuta, Daisuke Chinda, Tatsuya Mikami, Shinsaku Fukuda
Intest Res. 2022;20(1):90-100.   Published online January 22, 2021
Full text    PubReader    ePub    PDF    Supplementary Material
Close layer
prev next
Biomarker dynamics during infliximab salvage for acute severe ulcerative colitis: C-reactive protein (CRP)-lymphocyte ratio and CRP-albumin ratio are useful in predicting colectomy
Danny Con, Bridgette Andrew, Steven Nicolaides, Daniel R van Langenberg, Abhinav Vasudevan
Intest Res. 2022;20(1):101-113.   Published online March 12, 2021
Full text    PubReader    ePub    PDF    Supplementary Material
Close layer
prev next
Incidence comparison of adverse events in patients with inflammatory bowel disease receiving different biologic agents: retrospective long-term evaluation
Brigida Barberio, Edoardo Vincenzo Savarino, Timothy Card, Cristina Canova, Francesco Baldisser, Alessandro Gubbiotti, Davide Massimi, Matteo Ghisa, Fabiana Zingone
Intest Res. 2022;20(1):114-123.   Published online August 4, 2021
Full text    PubReader    ePub    PDF    Supplementary Material
Close layer
prev next
Functional bowel disorder
An evaluation of dietary adequacy among patients with constipation-predominant irritable bowel syndrome in Malaysia
Nor Hamizah Shafiee, Nurul Huda Razalli, Norfilza M. Mokhtar, Eunice Tan, Raja Affendi Raja Ali
Intest Res. 2022;20(1):124-133.   Published online January 22, 2021
Full text    PubReader    ePub    PDF    
Close layer
prev next
IBD
Clinical presentation of COVID-19 in patients with inflammatory bowel disease: a systematic review and meta-analysis
Anupam K. Singh, Anuraag Jena, Praveen Kumar-M, Daya Krishna Jha, Vishal Sharma
Intest Res. 2022;20(1):134-143.   Published online January 18, 2021
Full text    PubReader    ePub    PDF    Supplementary Material
Close layer
prev next
Case Reports
Miscellaneous
A case of autoimmune enteropathy with CTLA4 haploinsufficiency
Haruka Miyazaki, Namiko Hoshi, Michitaka Kohashi, Eri Tokunaga, Yuna Ku, Haruka Takenaka, Makoto Ooi, Nobuyuki Yamamoto, Suguru Uemura, Noriyuki Nishimura, Kazumoto Iijima, Keisuke Jimbo, Tsubasa Okano, Akihiro Hoshino, Kohsuke Imai, Hirokazu Kanegane, Ichiro Kobayashi, Yuzo Kodama
Intest Res. 2022;20(1):144-149.   Published online January 22, 2021
Full text    PubReader    ePub    PDF    
Close layer
prev next
IBD
Granulocyte and monocyte apheresis therapy for patients with active ulcerative colitis associated with COVID-19: a case report
Miki Koroku, Teppei Omori, Harutaka Kambayashi, Shun Murasugi, Tomoko Kuriyama, Yuichi Ikarashi, Maria Yonezawa, Ken Arimura, Kazunori Karasawa, Norio Hanafusa, Masatoshi Kawana, Katsutoshi Tokushige
Intest Res. 2022;20(1):150-155.   Published online March 12, 2021
Full text    PubReader    ePub    PDF    
Close layer
prev next
  • Journal Impact Factor 4.9
  • SCImago Journal & Country Rank
  • AOCC 2018
  • CSIBD
  • JSIBD
  • kasid
  • TSIBD
  • CCF
  • PubMed Central
  • PubMed
  • KoreaMed
  • KoMCI
  • Scopus
  • Directory of Open Access Journals (DOAJ)
  • GoogleScholar
  • EBSCO
  • Similarity Check
  • Crossref Cited-by Linking
  • CrossMark
  • Funder Registry
  • ORCID
  • COPE
  • KOFST
  • TrendMD


ABOUT
ARTICLE & TOPICS
Article Category

Browse all articles >

TOPICS

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
AUTHOR INFORMATION
Editorial Office
Room 310, Lotte Gold Rose II, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-957-6145    Fax: +82-2-957-6146    E-mail: thekasid@irjournal.org                

Copyright © 2024 by Korean Association for the Study of Intestinal Diseases.

Developed in M2PI

Close layer
prev next